logo
A windfall is coming for India's surging defence exports

A windfall is coming for India's surging defence exports

Time of India3 days ago

The stock market movement today could be a signifier of big things in store for India's defence export companies.
Defence stocks
such as Sika Interplant Systems, Data Patterns, BEL and BEML rose up to 5% on Thursday morning. The trigger was a NATO announcement. India's defence sector, once considered heavily import-dependent, is now emerging as a credible global supplier. In recent years, a series of policy reforms, investments and growing industrial capabilities have propelled Indian defence exports to new highs. Now, a windfall is taking shape which can boost India's defence exports further. NATO has announced at the recent summit in The Hague to increase member nations' defence spending to 5% of GDP by 2035.
The convergence of NATO's spending surge, Europe's quest for strategic autonomy and India's growing defence manufacturing capability has created a rare alignment of interest and opportunity. For Indian defence manufacturers, the coming decade may well mark a transformational phase, one that could redefine the country's role in global military supply chains.
Reliance deal is a precursor of a windfall
Reliance
Defence has secured Rs 600 crore worth of export order from Germany's leading defence manufacturer Rheinmetall Waffe Munition GmbH. Following its recently announced strategic partnership with Rheinmetall, this order is one of the largest contracts in the high-tech ammunition domain. Reliance will supply ammunition like artillery shells and explosives from a new facility to be set up in Maharashtra.
The deal comes after Reliance Defence's joint ventures with
Dassault Aviation
and Thales of France. Recently, Reliance Defence, a subsidiary of
Reliance Infrastructure
, also entered into a strategic cooperation agreement with Germany's Diehl Defence. The partnership will focus on the local production of the Vulcano 155mm precision-guided munition system, an advanced artillery shell designed for long-range, high-accuracy strikes.
Live Events
You Might Also Like:
Reliance Defence secures Rs 600 cr export order from Rheinmetall Germany
Reliance Defence deal with Rheinmetall could be a precursor of a windfall as Europe's planned hike in defence spending will offer more opportunities for Indian defence manufacturers, especially for supply of sub-systems, components, ammunition and other equipment as well as joint projects.
Why India can be a preferred defence supplier to NATO countries
NATO's move stems from a growing recognition of geopolitical volatility and strategic vulnerability. Russia's war in Ukraine has exposed the military deficiencies of several European nations and underscored their dependency on the US for security guarantees and military equipment. As a result, the alliance is now aiming for deeper self-reliance and rapid capacity enhancement. Raising defence spending to 5% of GDP is not just symbolic; it translates to hundreds of billions of dollars in additional defence outlay annually across NATO members. Meeting this demand through existing supply chains will be challenging, especially in Europe, where defence manufacturing capacity is limited, and workforce shortages are acute.
Further adding momentum to this shift is the Draghi report on EU competitiveness. Authored by former ECB President Mario Draghi, the report calls for a comprehensive revitalisation of Europe's industrial capacity, with a strong emphasis on achieving strategic autonomy in the defence sector. Crucially, it recommends reducing the EU's reliance on the US for defence imports and instead investing more within Europe.
However, building up this capacity will take years, and in the interim, the EU will need reliable, cost-effective external partners to bridge the gap. India, with its increasingly advanced defence manufacturing capabilities and growing diplomatic ties with Europe, is uniquely positioned to fill this role. Moreover, an expanded defence manufacturing base in Europe will also need component suppliers which can be an opportunity for India's growing defence industrial base with a large number of small and big private players.
You Might Also Like:
Dassault, Reliance revive Falcon jet manufacturing tie-up
India's defence export surge
Amidst a push for 'Atmanirbhar Bharat', India's defence exports reached a record high of Rs 23,622 crore (approximately $2.76 billion) in the last financial year 2024-25. Compared to the previous fiscal year's figure of Rs 21,083 crore, this represents an increase of Rs 2,539 crore, equivalent to a 12.04% growth. As per the Ministry of Defence (MoD), India already exports to around 80 countries and aims for Rs 50,000 crore in exports by 2029, strengthening its global defence manufacturing footprint. Compared to a revenue of Rs 686 crore in FY 2013-14, the FY 2024-25 number of Rs 23,622 crore is a 34 times increase, as per the MoD.
The export performance of Defence Public Sector Undertakings (DPSUs) has demonstrated substantial improvement with a 42.85% increase in FY 2024-25, indicating strong international acceptance of Indian defence products and the sector's capability to integrate into global supply networks, as per the MoD. In FY 2024-25, private sector contributions amounted to Rs 15,233 crore, whilst DPSUs generated Rs 8,389 crore in exports. These figures show an improvement from FY 2023-24, when private sector exports stood at Rs 15,209 crore and DPSU exports at Rs 5,874 crore.
The government has implemented numerous policy changes in recent years to strengthen India's defence sector, MoD said. These include streamlining industrial licensing processes, deregulating components from licensing requirements, and lengthening license validity periods. Furthermore, during the previous financial year, the Standard Operating Procedure for export authorisation underwent simplification, with additional provisions introduced to enhance the country's export capabilities.
You Might Also Like:
What does NATO's 5% spending deal really mean?
Public sector companies such as
Hindustan Aeronautics Limited
(HAL) and Bharat Electronics Limited (BEL) have been at the forefront, but the private sector is rapidly catching up. The entry of major conglomerates like Larsen & Toubro,
Tata Advanced Systems
and Reliance Defence has created a dynamic and competitive ecosystem.
India's edge: Cost, capacity and credibility
India's defence sector is poised for substantial growth amid global shifts, according to a recent report by brokerage firm Nuvama. Defence exports are expected to reach Rs 203 billion in FY25, with a government target of Rs 500 billion by FY29. European defence orders could begin flowing as early as the first half of FY26, marking a major milestone for the sector. Given Europe's manufacturing constraints, Indian defence companies are well-positioned to capitalize on rising export opportunities.
Europe's limited local manufacturing capacity and workforce shortages are opening doors for Indian defence manufacturers to step in. "Europe's defence expansion is constrained by limited local manufacturing capacity and skilled workforce shortages, especially in aerospace and missile supply chains. As a result, European nations are increasingly looking at partnerships and collaborations with Indian defence manufacturers," Nuvama said. This creates an environment where Indian defence manufacturers can step in, not just as low-cost suppliers but as serious contributors to high-tech systems and platforms too.
India's competitive advantage lies in its cost structure, manufacturing capacity and rapidly maturing technological base. Its large, skilled workforce and expanding industrial infrastructure give it the scalability that many European countries currently lack. Furthermore, India's recent advances in defence R&D, ranging from the Tejas light combat aircraft and
BrahMos
missiles to UAVs and naval systems, have increased its credibility as a supplier of complete solutions, not just parts.
This opportunity is as much geopolitical as it is commercial. India is seen as a neutral, democratic and increasingly strategic partner by many European nations. Unlike imports from China or Russia, Indian defence exports come with fewer political strings and are more acceptable in terms of values and alignment. This strategic trust could lead to deeper cooperation beyond simple exports, including co-development initiatives, joint ventures and technology partnerships in critical sectors such as artificial intelligence, cyber warfare, electronic systems and autonomous weapons.
However, the road ahead is not without challenges. Indian firms must meet stringent NATO quality standards and ensure timely deliveries, especially in an industry where reliability is paramount. Regulatory bottlenecks, such as export licensing and customs clearances, need to be streamlined further. The government's continued support in terms of policy clarity, R&D funding, and export facilitation will be critical. Additionally, India must focus on moving up the value chain -- from supplying components and subsystems to offering full-fledged platforms and integrated systems.
You Might Also Like:
NATO allies agree to hike defence spending, reaffirm collective defence

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Torrent Pharma to acquire JB Pharma from KKR at ₹25,689 cr valuation
Torrent Pharma to acquire JB Pharma from KKR at ₹25,689 cr valuation

Business Standard

time28 minutes ago

  • Business Standard

Torrent Pharma to acquire JB Pharma from KKR at ₹25,689 cr valuation

In one of the largest pharma deals in the domestic market in recent years, Ahmedabad-based Torrent Pharmaceuticals will acquire a controlling stake in investment firm KKR-backed JB Chemicals and Pharmaceuticals (known as JB Pharma) at an equity valuation of ₹25,689 crore, which will be followed by the merger of the two entities. The deal will be executed in two phases — acquisition of the 46.39 per cent stake held by KKR in JB Pharma at ₹1,600 per share, amounting to ₹11,917 crore, followed by a mandatory open offer to acquire up to 26 per cent of JB Pharma shares from public shareholders at ₹1,639.18 per share. 'In addition to the above, Torrent has also expressed its intent to acquire up to 2.8 per cent of equity shares from certain employees of JB Pharma at the same price per share as KKR,' the company said in a statement on Sunday. The next step in the deal will be a merger between Torrent Pharma and JB Pharma through a scheme of arrangement, under which every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent Pharma. The boards of directors of both companies have approved this arrangement. KKR had acquired 54 per cent of JB Pharma in July 2020 from the promoters and founders, the Mody family, for approximately ₹3,100 crore (or ₹745 per share). It sold a part of its stake in March this year through block deals for ₹1,459.8 crore. KKR has earned more than five times on its investment, with around 36 per cent gross IRR. For instance, Torrent Pharma has previously indicated plans to increase its medical representative (MR) strength by 23 per cent by the end of FY26, and the acquisition can aid in manpower augmentation. Torrent Pharma holds a 3.74 per cent share in the domestic market (according to Pharmarack, May 2025), while JB Pharma commands a 1.12 per cent share. Further, consolidation in key international markets is expected to offer greater scalability. Samir Mehta, executive chairman of Torrent Pharma, said they want to build on JB Pharma's heritage and platform for the future. 'Torrent's deep India presence and JB Pharma's fast-growing India business, combined with the CDMO and international footprint, offer immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market and builds a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.' Torrent has previously taken the inorganic route to grow its business and enter newer segments — in 2013, it acquired Elder Pharma's India-branded business; followed by the dermaceutical business of Zyg Pharma in 2015 and the API plant of Glochem Industries in 2016. Among other major deals, it bought the India-branded business of Unichem in 2017. Its last major acquisition was of skin-care products from Curatio Healthcare in 2022. Torrent Pharma is a highly domestic-focused company, drawing around 55 per cent of its consolidated revenues from the domestic formulations business. India sales grew by 13 per cent in FY25 to ₹6,393 crore. While the company has been outperforming industry growth in the domestic market, it is also planning to increase MR strength by 23 per cent by FY26-end. Torrent has a strong presence in the cardiovascular, gastrointestinal and neurology segments. JB too has prominent cardiac and gastro brands like Cilacar, Metrogyl and Rantac. Torrent is also working on launching GLP-1 products as a day-one launch in FY26. Analysts expect a 15 per cent sales CAGR in domestic formulations for Torrent Pharma over FY25–27. Gaurav Trehan, co-head of Asia Pacific and head of Asia Pacific private equity at KKR, and CEO of KKR India, said: 'JB Pharma's transformation under our stewardship is a testament to KKR's ability to scale high-quality companies.' Nikhil Chopra, chief executive officer and whole-time director of JB Pharma, pointed out that over the past five years, the company has emerged as one of India's fastest-growing pharmaceutical players. 'We have built a strong foundation to deliver market-leading growth, as well as consistent improvement in profitability in the medium and long term. As we now enter a new chapter alongside Torrent Pharmaceuticals, we are confident that the combined strengths of our organisations will unlock greater opportunities to enhance healthcare access across our markets,' Chopra said. JB Pharma posted 12 per cent revenue growth in FY25 to ₹3,918 crore, while its EBITDA rose 16 per cent to ₹1,087 crore, and PAT increased 19 per cent to ₹660 crore. Notably, KKR Private equity has invested $2 billion in India in 2024 and recently invested $600 million in Manipal Group via its private credit arm.

NSEL investors forum seeks Maharashtra CM's support for Rs 1,950-crore settlement
NSEL investors forum seeks Maharashtra CM's support for Rs 1,950-crore settlement

Time of India

time32 minutes ago

  • Time of India

NSEL investors forum seeks Maharashtra CM's support for Rs 1,950-crore settlement

File photo of Maharashtra chief minister Devendra Fadnavis (PTI) NEW DELHI: The NSEL Investors Forum (NIF) has written to Maharashtra chief minister Devendra Fadnavis, seeking his support for a proposed one-time settlement worth Rs 1,950 crore between investors and the National Spot Exchange Ltd (NSEL). This long-awaited settlement aims to bring major relief to thousands of traders whose funds have remained stuck since the NSEL payment crisis of July 2013. In a letter addressed to the chief minister on June 19, the forum appealed to the state government to avoid any adverse actions that could hinder the settlement process. It stated that "any decent or negative response from the State/ Competent Authority/ EOW in the NCLT might derail or delay the settlement process." To facilitate a smooth resolution, the forum has requested the state government to designate a senior legal expert with expertise in company law to represent and guide the state's stance before the NCLT. "We humbly urge the chief minister to issue necessary directions to relevant authorities and departments to avoid any hasty or negative steps that may derail or delay the proposed settlement," the forum stated. The forum emphasized that after nearly 12 years of chasing various recovery mechanisms, a consensus has finally been achieved between NSEL and its investors. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Adidas Three Shorts With 60% Discount, Limited Stock Available Original Adidas Shop Now Undo The proposed settlement scheme has been formally submitted under the Companies Act to the National Company Law Tribunal (NCLT), Mumbai, marking a major step toward closure for affected traders. As per the settlement plan, a total of Rs 1,950 crore will be distributed among 5,682 traders in proportion to their outstanding dues as of July 31, 2024. The NCLT has already admitted the company petition, with the final hearing scheduled for July 11. NSEL, supported by its parent company 63 moons technologies, filed the Scheme of Settlement before the NCLT to facilitate this one-time, amicable, and full-and-final resolution for the affected traders. The proposal itself originated from the NSEL Investors Forum (NIF), which represents a significant portion of the impacted trading community. This is not the first time NSEL and 63 moons have attempted to offer relief. In August 2013, they disbursed around Rs 179 crore to assist 7,053 smaller traders, each with outstanding amounts of less than Rs 10 lakh. PTI

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store